Rajasthan Bans Fake Oxytocin Batch After Maternal Deaths Post C-Section
Following the deaths of several women after Caesarean deliveries and uterine surgeries in Rajasthan, health authorities banned a batch of oxytocin injections found to be fake. Oxytocin, a hormone that helps the uterus contract post-childbirth to prevent severe bleeding, is widely used and considered life-saving in maternity care globally. Medical experts emphasize that administering oxytocin after C-sections is standard practice to reduce maternal mortality, underscoring the importance of authentic medication.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. Coverage leans balanced overall (Left 5%, Centre 93%, Right 2%). Overall sentiment is neutral (45/100). Lens Score 45/100 — moderate-to-low public interest.
Outlets analysed (first-hand measurement by TBN's Bias Engine):
- timesnow— balanced framing, neutral sentiment
- indiatoday— balanced framing, neutral sentiment
AI Analysis
The articles primarily present medical and regulatory perspectives without evident political framing. They focus on health authorities' actions and expert medical opinions, representing government regulatory responses and healthcare professionals' views. There is no partisan commentary or political interpretation, maintaining a neutral stance centered on public health concerns.
The overall tone is serious and cautionary, reflecting concern over maternal deaths linked to a counterfeit drug batch. However, the coverage also highlights the essential role of oxytocin in maternity care, balancing the negative incident with reassurance about the drug's medical importance. The sentiment is thus mixed, combining alarm over the fake medicine with confidence in standard medical practices.
How 2 sources covered this story
Each source's own headline, political lean, and sentiment — so you can see framing differences at a glance.